$1.43
-0.12-7.74%
At close: -
$1.45
0.021.41%
After Hours: 5:25 PM EDT
Comments
Loading...
Nkarta Insider Trading Activity | NASDAQ:NKTX | Benzinga
Track the latest Nkarta insider trading activity. Stay informed on recent buys, sells, and market impact for Nkarta stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Nkarta Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 17, 2025, Alyssa Levin, the company's SEE REMARKS sold 5.84K shares for $2.2 each.
- On January 17, 2025, Ralph Brandenberger, the company's CHIEF TECHNICAL OFFICER sold 7.45K shares for $2.2 each.
- On January 17, 2025, David Shook, the company's SEE REMARKS sold 8.64K shares for $2.2 each.
Ownership Statistics for Nkarta Inc
Shares Outstanding
70.569M
Insider Shares Owned
1.180M
Insider Percentage Owned
1.67%
Institutional Shares Held
15.689M
Institutional Percentage Held
22.2%
| Jan 17, 2025 | David Shook | SEE REMARKS | -8.64K | $2.20 | -$19.00K | SELL | -4.33% | 190.96K | Jan 15 | View |
| Jan 17, 2025 | Alyssa Levin | SEE REMARKS | -5.84K | $2.20 | -$12.84K | SELL | -5.38% | 102.66K | Jan 15 | View |
| Jan 17, 2025 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | -7.45K | $2.20 | -$16.38K | SELL | -5.63% | 124.80K | Jan 15 | View |
| Jan 17, 2025 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -17.38K | $2.20 | -$38.23K | SELL | -5.15% | 319.86K | Jan 15 | View |
| Jan 17, 2025 | Alicia Hager | CHIEF LEGAL OFFICER | -9.58K | $2.20 | -$21.08K | SELL | -6.13% | 146.74K | Jan 15 | View |
| Jul 18, 2024 | Alicia Hager | CHIEF LEGAL OFFICER | -3.40K | $8.00 | -$27.17K | SELL | -3.17% | 103.82K | Jul 16 | View |
| Jun 20, 2024 | James Trager | CHIEF SCIENTIFIC OFFICER | -456.00 | $5.60 | -$2.55K | SELL | -0.30% | 150.96K | Jun 18 | View |
| Jun 20, 2024 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -1.77K | $5.60 | -$9.91K | SELL | -0.73% | 240.74K | Jun 18 | View |
| Jun 20, 2024 | David Shook | CHIEF MEDICAL OFFICER | -456.00 | $5.60 | -$2.55K | SELL | -0.39% | 116.52K | Jun 18 | View |
| Jun 20, 2024 | Alicia Hager | CHIEF LEGAL OFFICER | -727.00 | $5.60 | -$4.07K | SELL | -0.67% | 107.22K | Jun 18 | View |
| Jun 20, 2024 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | -229.00 | $5.60 | -$1.28K | SELL | -0.29% | 79.74K | Jun 18 | View |
| Mar 29, 2024 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund LPPeter KolchinskyRajeev Shah | DIRECTOR | 3.00M | $10.00 | $30.00M | BUY | 38.44% | 10.81M | Mar 27 | View |
| Mar 28, 2024 | Simeon George | — | 2.00M | $10.00 | $20.00M | BUY | ∞ | 1.12M | Mar 27 | View |
| Mar 05, 2024 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | -1.60K | $8.20 | -$78.36K | SELL | -1.97% | 79.97K | Mar 01 | View |
| Feb 14, 2024 | James Trager | CHIEF SCIENTIFIC OFFICER | -4.14K | $12.00 | -$49.72K | SELL | -2.70% | 149.41K | Feb 12 | View |
| Jan 18, 2024 | David Shook | CHIEF MEDICAL OFFICER | -3.55K | $8.74 | -$31.04K | SELL | -3.00% | 114.98K | Jan 16 | View |
| Jan 18, 2024 | James Trager | CHIEF SCIENTIFIC OFFICER | -4.56K | $8.74 | -$39.85K | SELL | -2.88% | 153.56K | Jan 16 | View |
| Jan 18, 2024 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | -2.51K | $8.74 | -$21.95K | SELL | -2.99% | 81.58K | Jan 16 | View |
| Jan 18, 2024 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -9.70K | $8.74 | -$84.75K | SELL | -2.42% | 390.51K | Jan 16 | View |
| Jan 18, 2024 | Alicia Hager | CHIEF LEGAL OFFICER | -4.55K | $8.74 | -$39.80K | SELL | -4.05% | 107.94K | Jan 16 | View |
| Aug 23, 2023 | David Shook | CHIEF MEDICAL OFFICER | -1.33K | $1.83 | -$2.44K | SELL | -2.15% | 60.53K | Aug 21 | View |
| Jun 22, 2023 | James Trager | CHIEF SCIENTIFIC OFFICER | -439.00 | $4.85 | -$2.13K | SELL | -0.44% | 100.12K | Jun 20 | View |
| Jun 22, 2023 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | -221.00 | $4.85 | -$1.07K | SELL | -0.78% | 28.09K | Jun 20 | View |
| Jun 22, 2023 | Alicia Hager | CHIEF LEGAL OFFICER | -701.00 | $4.85 | -$3.40K | SELL | -1.23% | 56.50K | Jun 20 | View |
| Jun 22, 2023 | David Shook | CHIEF MEDICAL OFFICER | -439.00 | $4.85 | -$2.13K | SELL | -0.70% | 61.86K | Jun 20 | View |
| Jun 22, 2023 | Nadir Mahmood | SEE REMARKS | -526.00 | $4.85 | -$2.55K | SELL | -0.61% | 85.78K | Jun 20 | View |
| Jun 22, 2023 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -1.70K | $4.85 | -$8.26K | SELL | -0.54% | 313.40K | Jun 20 | View |
| Jan 18, 2023 | James Trager | CHIEF SCIENTIFIC OFFICER | 36.38K | $5.49 | -$6.12K | GRANT | 58.52% | 98.56K | Jan 13 - Jan 17 | View |
| Jan 18, 2023 | David Shook | CHIEF MEDICAL OFFICER | 37.33K | $5.49 | -$960.75 | GRANT | 162.45% | 60.30K | Jan 13 - Jan 17 | View |
| Jan 18, 2023 | Nadir Mahmood | SEE REMARKS | 36.38K | $5.49 | -$6.16K | GRANT | 75.91% | 84.30K | Jan 13 - Jan 17 | View |
| Jan 18, 2023 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | 60.81K | $5.49 | -$20.26K | GRANT | 24.10% | 313.11K | Jan 13 - Jan 17 | View |
| Jan 18, 2023 | Alicia Hager | CHIEF LEGAL OFFICER | 36.40K | $5.49 | -$6.06K | GRANT | 174.99% | 57.20K | Jan 13 - Jan 17 | View |
| Jan 18, 2023 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | 20.51K | $5.49 | -$2.70K | GRANT | 262.94% | 28.31K | Jan 13 - Jan 17 | View |
| Oct 07, 2022 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | 0.00 | $8.96 | -$8.53K | SELL-OPTIONS | 0.00% | 7.80K | Oct 06 | View |
| Sep 30, 2022 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -23.87K | $13.03 | -$311.09K | SELL | -8.70% | 250.46K | Sep 28 - Sep 29 | View |
| Sep 22, 2022 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -6.13K | $13.01 | -$79.72K | SELL | -2.18% | 274.33K | Sep 21 | View |
| Aug 17, 2022 | James Trager | CHIEF SCIENTIFIC OFFICER | 0.00 | $10.71 | -$68.21K | SELL-OPTIONS | 0.00% | 62.17K | Aug 15 | View |
| Aug 17, 2022 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | 0.00 | $10.77 | -$151.26K | SELL-OPTIONS | 0.00% | 7.80K | Aug 15 | View |
| Aug 17, 2022 | Nadir Mahmood | SEE REMARKS | 0.00 | $10.96 | -$106.04K | SELL-OPTIONS | 0.00% | 46.09K | Aug 15 | View |
| Aug 10, 2022 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | 0.00 | $9.06 | -$149.58K | SELL-OPTIONS | 0.00% | 7.80K | Aug 08 | View |
| Aug 10, 2022 | Nadir Mahmood | SEE REMARKS | 0.00 | $9.61 | -$85.72K | SELL-OPTIONS | 0.00% | 46.09K | Aug 08 | View |
| Jul 26, 2022 | Ralph Brandenberger | CHIEF TECHNICAL OFFICER | 0.00 | $6.91 | -$39.00K | SELL-OPTIONS | 0.00% | 7.80K | Jul 25 | View |
| Jul 26, 2022 | Nadir Mahmood | SEE REMARKS | 0.00 | $8.64 | -$71.30K | SELL-OPTIONS | 0.00% | 46.09K | Jul 25 | View |
| Jun 07, 2022 | Ralph Brandenberger | SR. VP, TECHNICAL OPERATIONS | 0.00 | $9.35 | -$46.82K | SELL-OPTIONS | 0.00% | 5.30K | Jun 03 | View |
| Apr 29, 2022 | Simeon George | DIRECTOR | 1.33M | $15.00 | $20.00M | BUY | ∞ | 666.67K | Apr 28 | View |
| Apr 28, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund LPPeter KolchinskyRajeev Shah | DIRECTOR | 2.20M | $15.00 | $33.00M | BUY | 39.25% | 7.81M | Apr 26 | View |
| Dec 03, 2021 | Ralph Brandenberger | SR. VP, TECHNICAL OPERATIONS | 0.00 | $9.67 | -$49.47K | SELL-OPTIONS | 0.00% | 0.00 | Dec 01 | View |
| Oct 01, 2021 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -8.50K | $27.18 | -$231.05K | SELL | -3.74% | 219.06K | Sep 29 | View |
| Sep 02, 2021 | Ralph Brandenberger | SEE REMARKS | 0.00 | $17.89 | -$117.53K | SELL-OPTIONS | 0.00% | 0.00 | Sep 01 | View |
| Aug 09, 2021 | Kanya Rajangam | CHIEF MEDICAL OFFICER | 0.00 | $18.84 | -$368.70K | SELL-OPTIONS | 0.00% | 0.00 | Aug 05 | View |
| Aug 04, 2021 | James Trager | CHIEF SCIENTIFIC OFFICER | -1.35K | $17.71 | -$104.76K | SELL | -2.95% | 44.37K | Aug 02 | View |
| Jul 06, 2021 | Nadir Mahmood | SEE REMARKS | -3.00K | $17.80 | -$192.50K | SELL | -9.90% | 27.29K | Jul 01 | View |
| Jun 23, 2021 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -8.50K | $26.61 | -$226.22K | SELL | -3.60% | 227.56K | Jun 21 | View |
| Jun 04, 2021 | Ralph Brandenberger | SEE REMARKS | 0.00 | $14.10 | -$86.15K | SELL-OPTIONS | 0.00% | 0.00 | Jun 02 | View |
| May 12, 2021 | Nadir Mahmood | SEE REMARKS | -3.00K | $27.16 | -$81.48K | SELL | -9.53% | 28.49K | May 10 | View |
| May 05, 2021 | James Trager | CHIEF SCIENTIFIC OFFICER | -1.35K | $17.77 | -$105.15K | SELL | -2.87% | 45.72K | May 03 | View |
| Apr 02, 2021 | Nadir Mahmood | SEE REMARKS | 0.00 | $18.30 | -$100.84K | SELL-OPTIONS | 0.00% | 31.49K | Apr 01 | View |
| Apr 01, 2021 | PAUL HASTINGS | CHIEF EXECUTIVE OFFICER | -17.00K | $30.74 | -$522.54K | SELL | -6.72% | 236.06K | Mar 30 | View |
| Feb 03, 2021 | James Trager | CHIEF SCIENTIFIC OFFICER | -1.35K | $25.48 | -$192.08K | SELL | -2.79% | 47.07K | Feb 01 - Feb 02 | View |
| Jan 26, 2021 | Nadir Mahmood | SEE REMARKS | 0.00 | $26.23 | -$245.72K | SELL-OPTIONS | 0.00% | 31.49K | Jan 25 | View |
| Jul 16, 2020 | PLC GLAXOSMITHKLINE | — | 3.15M | $18.00 | $15.00M | DERIVATIVE CONVERSION | ∞ | 3.15M | Jul 14 | View |
| Jul 16, 2020 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | — | 2.79M | $18.00 | $10.00M | DERIVATIVE CONVERSION | ∞ | 2.79M | Jul 14 | View |
| Jul 16, 2020 | RA CAPITAL MANAGEMENT LPPeter KolchinskyRajeev Shah | — | 5.61M | $18.00 | $60.00M | DERIVATIVE CONVERSION | ∞ | 5.61M | Jul 14 | View |
| Jul 14, 2020 | James FlynnDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Mgmt LPDEERFIELD PARTNERS LP | — | 2.42M | $18.00 | $18.00M | DERIVATIVE CONVERSION | ∞ | 1.21M | Jul 14 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.